A Review of New Guidelines and Treatment Options for Obesity Please read through the following information and click Continue.
ACPE Universal Program Number: 0207-0000-16-001-H01-P and 0207-0000-16-001-H01-T Release Date: January 4, 2016 Expiration Date: January 4, 2019 Activity Type: Application-based
Statement of Need Obesity is a common diagnosis in the United States and affects more than one third of adults. As we learn more about obesity, there is an increasing interest in developing programs and treatments to both help prevent its development and lessen its negative effects. Obesity is defined by the World Health Organization as "abnormal or excessive fat accumulation that may impair health." Adults are commonly classified as being obese based on their body mass index (BMI). A BMI of greater than or equal to 25 kg/m2 is considered overweight and a BMI of greater than or equal to 30 kg/m2 is considered obese. Obesity is described as a national public health threat and is directly tied with an increased risk of morbidity and mortality. Pharmacists can play an important role in helping fight this threat.
Pharmacists Learning Objectives Upon successful completion of this activity, pharmacists should be better able to:
Pharmacy Technicians Learning Objectives Upon successful completion of this activity, pharmacy technicians should be better able to:
Any medications or treatment methods suggested in this activity should not be used by the practitioner without evaluation of their patient's condition(s) and possible contraindication(s) or danger(s) of use of any specific medication. This article contains a discussion of off-label uses that will be identified as such by the author.
Target Audience The target audience for this activity is Pharmacists and Pharmacy Technicians.
Instructions for Participation To receive a certificate of completion that indicates your eligibility for continuing education credit, you must:
Your statement of credit will be issued immediately upon successful completion of the post-test and submission of the evaluation.
Fee There is no fee for this activity.
Faculty Kylee Funk, PharmD, is a clinical faculty member of the University of Minnesota College of Pharmacy.
Disclosure Declaration It is the policy of the National Community Pharmacists Association (NCPA) to ensure independence, balance, objectivity, scientific rigor, and integrity in all of their continuing education activities.
The authors, sponsor, and publisher of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education program. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions) and drug delivery systems are subject to change, however, and the reader is advised to check the manufacturer's package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Approval of credit for this continuing education activity does not imply endorsement by NCPA of any product or manufacturer identified.
Any medications or treatment methods suggested in this CE activity should not be used by the practitioner without evaluation of their patient's condition(s) and possible contraindication(s) or danger(s) of use of any specific medication.
MAC Safari (Latest Version) Firefox (Latest Version) *Adobe Acrobat Reader